TipRanks
Tsumura & Co. (TSMRF)
OTHER OTC:TSMRF
US Market
TSMRF
Tsumura & Co
RESEARCH TOOLSreports

Tsumura & Co (TSMRF) Stock Forecast & Price Target

7 Followers
See the Price Targets and Ratings of:

TSMRF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Tsumura
& Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TSMRF Stock 12 Month Forecast

There Are No Analyst Ratings for TSMRF In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

TSMRF Financial Forecast

TSMRF Earnings Forecast

Next quarter’s earnings estimate for TSMRF is $0.69 with a range of $0.69 to $0.69. The previous quarter’s EPS was $0.55. TSMRF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year TSMRF has Performed in-line its overall industry.
Next quarter’s earnings estimate for TSMRF is $0.69 with a range of $0.69 to $0.69. The previous quarter’s EPS was $0.55. TSMRF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year TSMRF has Performed in-line its overall industry.

TSMRF Sales Forecast

Next quarter’s sales forecast for TSMRF is $345.32M with a range of $334.52M to $351.84M. The previous quarter’s sales results were $315.69M. TSMRF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year TSMRF has Performed in-line its overall industry.
Next quarter’s sales forecast for TSMRF is $345.32M with a range of $334.52M to $351.84M. The previous quarter’s sales results were $315.69M. TSMRF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year TSMRF has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - PerPlexity Analyst forecast on TSMRF
PerPlexity - SonarReasoningPro
TipRanks - PerPlexity
TipRanks - PerPlexity
$25.36→$26.46
Buy
13.62%
Upside
Reiterated
08/19/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on TSMRF
xAI - Grok-4.3
TipRanks - xAI
TipRanks - xAI
$26.52→$26.2
Hold
12.50%
Upside
Downgraded
08/09/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on TSMRF
Anthropic Drug Manufacturers - Specialty and Generic
TipRanks - Anthropic
TipRanks - Anthropic
$24.14→$24.16
Hold
3.74%
Upside
Reiterated
08/09/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on TSMRF
Google Drug Manufacturers - Specialty and Generic
TipRanks - Google
TipRanks - Google
$25.81→$26.32
Hold
13.02%
Upside
Reiterated
08/09/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on TSMRF
OpenAI - Gpt-5.6Sol
TipRanks - OpenAI
TipRanks - OpenAI
$25.45→$25.84
Hold
10.97%
Upside
Reiterated
08/09/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on TSMRF
DeepSeek - V4Pro
TipRanks - DeepSeek
TipRanks - DeepSeek
$25.21→$26.09
Hold
12.01%
Upside
Reiterated
08/09/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - PerPlexity Analyst forecast on TSMRF
PerPlexity - SonarReasoningPro
TipRanks - PerPlexity
TipRanks - PerPlexity
$25.36→$26.46
Buy
13.62%
Upside
Reiterated
08/19/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on TSMRF
xAI - Grok-4.3
TipRanks - xAI
TipRanks - xAI
$26.52→$26.2
Hold
12.50%
Upside
Downgraded
08/09/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on TSMRF
Anthropic Drug Manufacturers - Specialty and Generic
TipRanks - Anthropic
TipRanks - Anthropic
$24.14→$24.16
Hold
3.74%
Upside
Reiterated
08/09/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on TSMRF
Google Drug Manufacturers - Specialty and Generic
TipRanks - Google
TipRanks - Google
$25.81→$26.32
Hold
13.02%
Upside
Reiterated
08/09/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on TSMRF
OpenAI - Gpt-5.6Sol
TipRanks - OpenAI
TipRanks - OpenAI
$25.45→$25.84
Hold
10.97%
Upside
Reiterated
08/09/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on TSMRF
DeepSeek - V4Pro
TipRanks - DeepSeek
TipRanks - DeepSeek
$25.21→$26.09
Hold
12.01%
Upside
Reiterated
08/09/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
KURAKura Oncology
LFMDLifeMD
ACHVAchieve Life Sciences
ZYMEZymeworks
HROWHarrow Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tsumura & Co

3 Months
PerPlexity Drug Manufacturers - Specialty and GenericTipRanks - PerPlexity
Success Rate
1/2 ratings generated profit
50%
Average Return
-0.85%
Copying PerPlexity Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -0.85% per trade.
1 Year
PerPlexity Drug Manufacturers - Specialty and GenericTipRanks - PerPlexity
Success Rate
1/2 ratings generated profit
50%
Average Return
+0.65%
Copying PerPlexity Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +0.65% per trade.
2 Years
PerPlexity Drug Manufacturers - Specialty and GenericTipRanks - PerPlexity
Success Rate
1/2 ratings generated profit
50%
Average Return
+0.65%
Copying PerPlexity Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +0.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TSMRF Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, TSMRF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TSMRF average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

TSMRF Stock Forecast FAQ

What is TSMRF’s average 12-month price target, according to analysts?
Currently, no data Available
What is TSMRF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TSMRF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is TSMRF a Buy, Sell or Hold?
      Currently, no data Available
      What is Tsumura & Co.’s price target?
      Currently, no data Available
      What do analysts say about Tsumura & Co.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of TSMRF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.